Home | Publications | Treatments | Smoking cessation place holder
place holder place holder

Smoking cessation


NRT Smoking Cessation Aids in Japan


Publication Date   September 2007
Publisher   Euromonitor International
Product Type   Report
Pages   48
ISBN Number   not applicable
Product Code   EUR881
Ask a question about this product?

Price £450.00

approximately: $671 | €536

Summary


Euromonitor International's NRT Smoking Cessation Aids in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

  • Get a detailed picture of the smoking cessation aids industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


OTC Healthcare - New Zealand

OTC Healthcare in New Zealand : Market Insight

EXECUTIVE SUMMARY
A year of limited growth Consumers increasingly prepared to self-medicate OTC obesity - the rising star Pharmacies set to regain lost share Consolidation continues Sound and sustainable forecast KEY TRENDS AND DEVELOPMENTS
De-regulations encourage consumers for self-medication Pharmacies fighting back to secure top position in OTC retailing Ageing population stimulates OTC sales Continually changing face of OTC environment Preventive measures key to shaping demand for OTC healthcare products MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources

Local Company Profiles - New Zealand

Apotex NZ Ltd - OTC Healthcare - New Zealand
STRATEGIC DIRECTION KEY FACTS
Summary 2 Apotex NZ Ltd: Key Facts
Summary 3 Apotex NZ Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Apotex NZ Ltd: Competitive Position 2006
Douglas Pharmaceuticals Ltd - OTC Healthcare - New Zealand
STRATEGIC DIRECTION KEY FACTS
Summary 5 Douglas Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND PRODUCTION
Summary 6 Douglas Pharmaceuticals Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 7 Douglas Pharmaceuticals Ltd: Competitive Position 2006
Ebos Ltd - OTC Healthcare - New Zealand
STRATEGIC DIRECTION KEY FACTS
Summary 8 Ebos Group Ltd: Key Facts
Summary 9 Ebos Group Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 10 Ebos Group Ltd: Competitive Position 2006
Healtheries of New Zealand Ltd - OTC Healthcare - New Zealand
STRATEGIC DIRECTION KEY FACTS
Summary 11 Healtheries of New Zealand Ltd: Key Facts
Summary 12 Healtheries of New Zealand Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 13 Healtheries of New Zealand Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 14 Healtheries of New Zealand Ltd: Competitive Position 2006
Life Pharmacy Ltd - OTC Healthcare - New Zealand
STRATEGIC DIRECTION KEY FACTS
Summary 15 Life Pharmacy Ltd: Key Facts
Summary 16 Life Pharmacy Ltd: Operational Indicators
COMPANY BACKGROUND

Analgesics in New Zealand

HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011